144 related articles for article (PubMed ID: 18027870)
1. Differences in antitumor effects of various statins on human pancreatic cancer.
Gbelcová H; Lenícek M; Zelenka J; Knejzlík Z; Dvoráková G; Zadinová M; Poucková P; Kudla M; Balaz P; Ruml T; Vítek L
Int J Cancer; 2008 Mar; 122(6):1214-21. PubMed ID: 18027870
[TBL] [Abstract][Full Text] [Related]
2. Heme oxygenase is not involved in the anti-proliferative effects of statins on pancreatic cancer cells.
Vanova K; Boukalova S; Gbelcova H; Muchova L; Neuzil J; Gurlich R; Ruml T; Vitek L
BMC Cancer; 2016 May; 16():309. PubMed ID: 27175805
[TBL] [Abstract][Full Text] [Related]
3. Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.
Hao F; Xu Q; Wang J; Yu S; Chang HH; Sinnett-Smith J; Eibl G; Rozengurt E
PLoS One; 2019; 14(5):e0216603. PubMed ID: 31100067
[TBL] [Abstract][Full Text] [Related]
4. Variability in statin-induced changes in gene expression profiles of pancreatic cancer.
Gbelcová H; Rimpelová S; Ruml T; Fenclová M; Kosek V; Hajšlová J; Strnad H; Kolář M; Vítek L
Sci Rep; 2017 Mar; 7():44219. PubMed ID: 28276528
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Transcriptomic Profiles of MiaPaCa-2 Pancreatic Cancer Cells Treated with Different Statins.
Rimpelová S; Kolář M; Strnad H; Ruml T; Vítek L; Gbelcová H
Molecules; 2021 Jun; 26(12):. PubMed ID: 34207840
[TBL] [Abstract][Full Text] [Related]
6. Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update.
Schachter M
Fundam Clin Pharmacol; 2005 Feb; 19(1):117-25. PubMed ID: 15660968
[TBL] [Abstract][Full Text] [Related]
7. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
Ogunwobi OO; Beales IL
Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
9. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer.
Chen C; Wu H; Kong D; Xu Y; Zhang Z; Chen F; Zou L; Li Z; Shui J; Luo H; Liu SH; Yu J; Wang K; Brunicardi FC
Oncol Rep; 2020 Dec; 44(6):2569-2580. PubMed ID: 33125137
[TBL] [Abstract][Full Text] [Related]
10. HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins.
Wiesbauer F; Kaun C; Zorn G; Maurer G; Huber K; Wojta J
Br J Pharmacol; 2002 Jan; 135(1):284-92. PubMed ID: 11786505
[TBL] [Abstract][Full Text] [Related]
11. Comparison of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) as inhibitors of cytochrome P450 2C8.
Tornio A; Pasanen MK; Laitila J; Neuvonen PJ; Backman JT
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):104-8. PubMed ID: 15998357
[TBL] [Abstract][Full Text] [Related]
12. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice.
Russo E; Donato di Paola E; Gareri P; Siniscalchi A; Labate A; Gallelli L; Citraro R; De Sarro G
Pharmacol Res; 2013 Apr; 70(1):1-12. PubMed ID: 23253428
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
15. Pleiotropic effects of statins in atherosclerosis and diabetes.
Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
[TBL] [Abstract][Full Text] [Related]
16. d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells.
Hussein D; Mo H
Pancreas; 2009 May; 38(4):e124-36. PubMed ID: 19346993
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions.
Shitara Y; Sugiyama Y
Pharmacol Ther; 2006 Oct; 112(1):71-105. PubMed ID: 16714062
[TBL] [Abstract][Full Text] [Related]
18. Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.
Wong WW; Tan MM; Xia Z; Dimitroulakos J; Minden MD; Penn LZ
Clin Cancer Res; 2001 Jul; 7(7):2067-75. PubMed ID: 11448925
[TBL] [Abstract][Full Text] [Related]
19. Statins can inhibit proliferation of human breast cancer cells in vitro.
Seeger H; Wallwiener D; Mueck AO
Exp Clin Endocrinol Diabetes; 2003 Feb; 111(1):47-8. PubMed ID: 12605351
[TBL] [Abstract][Full Text] [Related]
20. HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins.
Dansette PM; Jaoen M; Pons C
Exp Toxicol Pathol; 2000 May; 52(2):145-8. PubMed ID: 10965989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
